Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Sanofi Confident Of Strategy As China Becomes No.3 Market

This article was originally published in PharmAsia News

Executive Summary

Generic competition to Plavix in Japan was one factor that contributed to China becoming Sanofi's third largest market globally after the US and Western EU by the end of last year, and the French group says it expects to continue to grow ahead of the Chinese market.



Related Companies